Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Anebulo Pharmaceuticals: Q3 Earnings Insights

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported its Q3 earnings results on Thursday, May 11, 2023 at 08:00 AM. Here’s what…
byBenzinga Insights
May 11, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported its Q3 earnings results on Thursday, May 11, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Anebulo Pharmaceuticals beat estimated earnings by 31.25%, reporting an EPS of $-0.11 versus an estimate of $-0.16.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 3.83% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Anebulo Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Seres Therapeutics

By Benzinga Insights
August 2, 2:41 PM
Seres Therapeutics (NASDAQ:MCRB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that Seres Therapeutics will report an earnings per share (EPS) of $-0.60.

MCRB